Generics across the Ocean: Production, regulation, and export of Indian antibiotics for African markets
Antimicrobial resistance (AMR) is one of the main global challenges of our time. AMR is often presented as a major threat to “modern medicine as we know it” (Chan 2016), endangering the way we are used to treat and prevent common infectious diseases and medical conditions, resulting in prolonged illness, disability and death. Being a common global problem, the burden of AMR is however unequally distributed, and rising resistance threatens to reverse global improvements in people’s health and wellbeing. The consequences of rising resistance are particularly severe in many low- and middle-income countries, due to lack of access to quality health care and medicines, and a variety of conditions in these countries that foster the emergence and spread of resistance. One crucial dimension of this problem is the rapidly increasing production and consumption of antibiotics in the global South, where drug regulation, surveillance and other means of AMR policy are mostly absent. India is one of the world’s leading antibiotics producers, with a growing export to African markets that are also highly unregulated. Little is currently known about this flow of antibiotics from India to Africa, and the socio-political, economic and historical factors that underpins it. Taking a historically informed ethnographic approach, this PhD project aims to develop a broad social, political and historical understanding of the production, regulation and export of Indian antibiotics for African markets, and to identify mechanisms that shape and govern the flow of antibiotics across the Indian Ocean.
Prosjektbeskrivelse med vedlegg
REK - Ikke behov
Prosjektet skal ikke fremskaffe ny kunnskap om helse og sykdom